14 results
·
30ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
LifeRay Intraoral Handheld X-ray System
FDA 510(k)
FDA Class 2
·Dental
CoRoent
FDA UDI
Nuvasive, Inc.·00887517631190·CoRoent Ant TLIF Ti, 14x11x30mm 15°
LCP
FDA UDI
Synthes GmbH·10886982166777·3.5MM LCP® MEDIAL DISTAL HUMERUS PLATE 14 HOLES...
Pomee
FDA UDI
POMEE CORPORATION·G15772413050·Rochester pean forceps 5 1/2" curved
Sure Comfort
FDA UDI
ALLISON MEDICAL, INC.·00786227130552·32G x 1/4" (6mm) Single use disposable pen need...
J & J INSTRUMENTS
FDA UDI
J & J INSTRUMENTS INC·00817524026146·ROCHESTER PEAN 5.5" CVD
Portex
FDA UDI
ICU MEDICAL, INC.·15019517070347·
RICHFUL POWDER-FREE VINYL PATIENT EXAMINATION GLOVES, CLEAR (NON-COLORED)
FDA 510(k)
FDA Class 1
·General Hospital
STRYKER BIOZIP SUTURE ANCHOR SYSTEM
FDA 510(k)
FDA Class 2
·Orthopedic
BD VACUTAINER® SST¿ II ADVANCE PLUS BLOOD COLLECTION TUBES
FDA Adverse Event
Malfunction
·BECTON, DICKINSON AND COMPANY (BD)·Product code JKA·May 22, 2024
OVER-THE-MATTRESS SENSOR PAD
FDA Adverse Event
Malfunction
·J. T. POSEY CO.·Product code KMI·September 2, 2011
HS III PROXIMAL SEAL SYTEM 3.8MM
FDA Adverse Event
MAQUET CARDIOVASCULAR, LLC·Product code DXC·September 4, 2014
TITANIUM HEXALOBE SET SCREW
FDA Adverse Event
Injury
·ALPHATEC SPINE INC·Product code NKB·July 22, 2013
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014